论文部分内容阅读
研究披露,在对I型糖尿病患者进行平均27年的追踪之后,与常规疗法相比,最初进行6.5年糖尿病强化治疗与全因死亡率的适度降低相关。基于得到证明的病情的减轻,糖尿病强化疗法如今是推荐的标准治疗;然而,I型糖尿病的死亡率是否在经过一个阶段的糖尿病强化治疗之后受到影响则尚未确定。根据文章的背景资料,在II型糖尿病的治疗中,将血糖水平降至接近非糖尿病的血糖浓度范围并非一直能降低死亡率。匹茨堡大学的Trevor J.Orchard,M.D.和同事对原先的强化治疗组与常规治疗组之间的死亡率是否有差异进行了检查,它们是“糖尿病控制与并
The study disclosed that initial 6.5-year intensive diabetes treatment was associated with a modest reduction in all-cause mortality compared with conventional therapy after an average of 27 years of follow-up of patients with type I diabetes. Diabetes intensive therapy is now the recommended standard of care based on the proven reduction of illness, however whether the mortality of type 1 diabetes is affected after one stage of intensive diabetes mellitus has not been established. According to the article’s background, reducing blood glucose levels to near non-diabetic blood glucose levels in treatment of type 2 diabetes does not consistently reduce mortality. Trevor J. Orchard, M.D. and colleagues at the University of Pittsburgh examined whether there was a difference in mortality between the original intensive-treatment group and the conventional treatment group, which is the ”